REGENERX BIOPHARMACEUTICALS
RGN
RGN was delisted on the 22nd of December, 2010.
2 hedge funds and large institutions have $70K invested in REGENERX BIOPHARMACEUTICALS in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
46% more capital invested
Capital invested by funds: $48K → $70K (+$22K)
50% less funds holding
Funds holding: 4 → 2 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Colony Group
Boston,
Massachusetts
|
-$3K |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WJWM
1
Williams Jones Wealth Management
New York
| $63K | – | – | – |
|
|
DBIA
2
Dumont & Blake Investment Advisors
Princeton,
New Jersey
| $7K | – | – | – |
|
|
CG
3
Colony Group
Boston,
Massachusetts
| – | -$3K | -15,000 | Closed |
|
|
4
Victory Capital Management
San Antonio,
Texas
| – | -$3K | -13,440 | Closed |
|
RGN Hedge Fund Activity: Q2 2020 in Review
2 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in REGENERX BIOPHARMACEUTICALS (RGN) for Q2 2020, worth a combined $70K — up 46% from $48K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of RGN and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Colony Group, exiting entirely with an estimated $3K sold.
- 2 institutional investors held REGENERX BIOPHARMACEUTICALS (RGN) as of Q2 2020, down from 4 in Q1 2020.
- Funds reported $70K of REGENERX BIOPHARMACEUTICALS stock for Q2 2020, up 46% quarter-over-quarter.
- 0 funds opened new REGENERX BIOPHARMACEUTICALS positions in Q2 2020 and 2 closed out, a net change of -2 holders.
- The largest REGENERX BIOPHARMACEUTICALS seller in Q2 2020 was Colony Group, an estimated $3K sold.
Based on aggregated 13F filings for Q2 2020.